AAQ1 Fundamental Analysis - AAP IMPLANTATE

Name: AAP IMPLANTATE (AAQ1) Stock
Brand: AAP IMPLANTATE
Rating: 2 (3 reviews)

Fundamental Rating

Overall AAQ1 gets a fundamental rating of 2 out of 10. We evaluated AAQ1 against 60 industry peers in the Health Care Equipment & Supplies industry. The financial health of AAQ1 is average, but there are quite some concerns on its profitability. AAQ1 is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

AAQ1 had negative earnings in the past year.

In the past 5 years AAQ1 always reported negative net income.

AAQ1 had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

AAQ1 has a Return On Assets of -25.96%. This is in the lower half of the industry: AAQ1 underperforms 78.33% of its industry peers.

With a Return On Equity value of -38.70%, AAQ1 is not doing good in the industry: 73.33% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
ROA	-25.96%
ROE	-38.7%
ROIC	N/A

ROA(3y)-27.22%

ROA(5y)-27.6%

ROE(3y)-50.99%

ROE(5y)-51.91%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 87.45%, AAQ1 belongs to the top of the industry, outperforming 96.67% of the companies in the same industry.

In the last couple of years the Gross Margin of AAQ1 has remained more or less at the same level.

AAQ1 does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	87.45%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.81%

GM growth 5Y-0.65%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

AAQ1 does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, AAQ1 has more shares outstanding

AAQ1 has more shares outstanding than it did 5 years ago.

Compared to 1 year ago, AAQ1 has an improved debt to assets ratio.

2.2 Solvency

AAQ1 has an Altman-Z score of -0.06. This is a bad value and indicates that AAQ1 is not financially healthy and even has some risk of bankruptcy.

AAQ1's Altman-Z score of -0.06 is on the low side compared to the rest of the industry. AAQ1 is outperformed by 78.33% of its industry peers.

AAQ1 has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.

AAQ1 has a better Debt to Equity ratio (0.03) than 88.33% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.03
Debt/FCF	N/A
Altman-Z	-0.06

ROIC/WACCN/A

WACC6.96%

2.3 Liquidity

AAQ1 has a Current Ratio of 2.40. This indicates that AAQ1 is financially healthy and has no problem in meeting its short term obligations.

The Current ratio of AAQ1 (2.40) is better than 70.00% of its industry peers.

A Quick Ratio of 1.24 indicates that AAQ1 should not have too much problems paying its short term obligations.

The Quick ratio of AAQ1 (1.24) is comparable to the rest of the industry.

		Industry Rank	Sector Rank
Current Ratio	2.4
Quick Ratio	1.24

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 68.18% over the past year.

The Revenue has been growing slightly by 6.32% in the past year.

AAQ1 shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.78% yearly.

EPS 1Y (TTM)68.18%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%21.53%

Revenue 1Y (TTM)6.32%

Revenue growth 3Y0.1%

Revenue growth 5Y0.78%

Sales Q2Q%-3.32%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

The Revenue is expected to grow by 11.66% on average over the next years. This is quite good.

EPS Next Y65%

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year15.38%

Revenue Next 2Y22.14%

Revenue Next 3Y12.95%

Revenue Next 5Y11.66%

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AAQ1. In the last year negative earnings were reported.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AAQ1. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for AAQ1!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

AAP IMPLANTATE

FRA:AAQ1 (11/7/2025, 7:00:00 PM)

1.44

-0.02 (-1.37%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)09-16 2025-09-16

Earnings (Next)N/A N/A

Inst Owners20.09%

Inst Owner ChangeN/A

Ins Owners10.14%

Ins Owner ChangeN/A

Market Cap20.03M

Revenue(TTM)12.20M

Net Income(TTM)-3.63M

Analysts42.22

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	1.64
P/FCF	N/A
P/OCF	N/A
P/B	2.14
P/tB	2.66
EV/EBITDA	N/A

EPS(TTM)-0.28

EYN/A

EPS(NY)-0.07

Fwd EYN/A

FCF(TTM)N/A

FCFYN/A

OCF(TTM)N/A

OCFYN/A

SpS0.88

BVpS0.67

TBVpS0.54

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-25.96%
ROE	-38.7%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	87.45%
FCFM	N/A

ROA(3y)-27.22%

ROA(5y)-27.6%

ROE(3y)-50.99%

ROE(5y)-51.91%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.81%

GM growth 5Y-0.65%

F-ScoreN/A

Asset Turnover0.87

Health

		Industry Rank	Sector Rank
Debt/Equity	0.03
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	2.4
Quick Ratio	1.24
Altman-Z	-0.06

F-ScoreN/A

WACC6.96%

ROIC/WACCN/A

Cap/Depr(3y)23.96%

Cap/Depr(5y)22.7%

Cap/Sales(3y)3.48%

Cap/Sales(5y)3.84%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)68.18%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%21.53%

EPS Next Y65%

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)6.32%

Revenue growth 3Y0.1%

Revenue growth 5Y0.78%

Sales Q2Q%-3.32%

Revenue Next Year15.38%

Revenue Next 2Y22.14%

Revenue Next 3Y12.95%

Revenue Next 5Y11.66%

EBIT growth 1Y63.22%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year173.33%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y57.21%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y62.43%

OCF growth 3YN/A

OCF growth 5YN/A

AAP IMPLANTATE / AAQ1.DE FAQ

What is the fundamental rating for AAQ1 stock?

ChartMill assigns a fundamental rating of 2 / 10 to AAQ1.DE.

What is the valuation status for AAQ1 stock?

ChartMill assigns a valuation rating of 0 / 10 to AAP IMPLANTATE (AAQ1.DE). This can be considered as Overvalued.

How profitable is AAP IMPLANTATE (AAQ1.DE) stock?

AAP IMPLANTATE (AAQ1.DE) has a profitability rating of 1 / 10.

What is the expected EPS growth for AAP IMPLANTATE (AAQ1.DE) stock?

The Earnings per Share (EPS) of AAP IMPLANTATE (AAQ1.DE) is expected to grow by 65% in the next year.

AAP IMPLANTATE (AAQ1.DE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

AAP IMPLANTATE / AAQ1.DE FAQ

What is the fundamental rating for AAQ1 stock?

What is the valuation status for AAQ1 stock?

How profitable is AAP IMPLANTATE (AAQ1.DE) stock?

What is the expected EPS growth for AAP IMPLANTATE (AAQ1.DE) stock?